Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M
2013
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK
2004
Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzaeinfection
2008 StandoutNobel
Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study
2008
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
2009 Standout
The CTX-M β-lactamase pandemic
2006
Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
2015
Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain
2015
Nocardiosis: Updates and Clinical Overview
2012 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients
2011
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Human Genetics Shape the Gut Microbiome
2014 Standout
The role of the gut microbiota in nonalcoholic fatty liver disease
2010
Epidemiology of sepsis: An update
2001
IRT and CMT β-lactamases and inhibitor resistance
2008
Excess Risk of Death from Intensive Care Unit--Acquired Nosocomial Bloodstream Infections: A Reappraisal
2006
Community-Acquired Bloodstream Infection in Critically Ill Adult Patients
2003
Infection Control — A Problem for Patient Safety
2003 Standout
Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations
2005
Infection Control in the ICU
2001
Sepsis: a roadmap for future research
2015
Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study
1999
Severe Sepsis and Septic Shock
2013 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
2011
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Emergence of Levofloxacin-Resistant Pneumococci in Immunocompromised Adults after Therapy for Community-Acquired Pneumonia
2003
Update in Adult Urinary Tract Infection
2011
Integrons and β-lactamases—a novel perspective on resistance
2004
Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998
1999
Minor extended-spectrum β-lactamases
2008
Pathogenic Escherichia coli
2004 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China
2002
Sepsis and septic shock
2018 Standout
Quinolone-Resistant Haemophilus influenzae in a Long-Term Care Facility: Clinical and Molecular Epidemiology
2004
Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-ResistantEscherichia coliClonal Group
2001
Nocardiosis at the Turn of the Century
2009 Standout
Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones
2012
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria
2012
Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study
2009
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
2007
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge
2006
Predicting a complicated course of Clostridium difficile infection at the bedside
2013
Foodborne Illness Acquired in the United States—Major Pathogens
2010 Standout
Ventilator-Induced Lung Injury
2013 Standout
The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit
2003
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
2000
Nosocomial Bacteremia in Critically Ill Patients: A Multicenter Study Evaluating Epidemiology and Prognosis
1997
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
2015
The etiology of urinary tract infection: traditional and emerging pathogens
2002
Uncomplicated Urinary Tract Infection
2012 Standout
Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients
2005
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Emerging drugs for the treatment of sepsis
2016
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases
2004
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Molecular epidemiology of an outbreak due to IRT-2 -lactamase-producing strains of Klebsiella pneumoniae in a geriatric department
2000
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Epidemiology of urinary tract infections
2003
Complete sequencing of an IncHI1 plasmid encoding the carbapenemase NDM-1, the ArmA 16S RNA methylase and a resistance-nodulation-cell division/multidrug efflux pump
2012
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*
2003
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Complete Sequence and Molecular Epidemiology of IncK Epidemic Plasmid EncodingblaCTX-M-14
2011
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
The New β-Lactamases
2005
The human microbiome: at the interface of health and disease
2012 Standout
CTX-M: changing the face of ESBLs in Europe
2006
The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care Unit
1999
Recurrent Pseudomonas aeruginosa Pneumonia in Ventilated Patients
1998
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Adverse Ventilatory Strategy Causes Pulmonary-to-Systemic Translocation of Endotoxin
2000
Association between Source of Infection and Hospital Mortality in Patients Who Have Septic Shock
2014
Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
1990 Standout
Ventilator-associated Pneumonia
2002 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Outcomes of Primary and Catheter-related Bacteremia
2001
Evaluation of Outcome of Intravenous Catheter-related Infections in Critically Ill Patients
2000
Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by MultipleKlebsiella pneumoniaeClones in a Single Hospital (Madrid, 1989 to 2000)
2002
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Effects of Inoculum and β-Lactamase Activity in AmpC- and Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates Tested by Using NCCLS ESBL Methodology
2004
Bacteriophages Carrying Antibiotic Resistance Genes in Fecal Waste from Cattle, Pigs, and Poultry
2011
Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year Period
2002
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
2010
Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 β-Lactamase Production
2003
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
2003
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Plasmidic Extended-Spectrum β-Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina
2002
Third-Generation Cephalosporin Resistance inShigella sonnei, Argentina
2001
Investigational treatments for postoperative surgical site infections
2007
CRISPR-Cas Systems
2012
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Metagenomics of the Human Body
2010
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Association between Fluoroquinolone Resistance and Mortality in Escherichia coli and Klebsiella pneumoniae Infections: The Role of Inadequate Empirical Antimicrobial Therapy
2005
The etiology of urinary tract infection: Traditional and emerging pathogens
2003
Carbapenemase-producingEnterobacteriaceae, U.S. Rivers
2005
Antibiotic Resistance in the Intensive Care Unit
2001
Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients
2004
Characterization of the Naturally Occurring Oxacillinase ofAcinetobacter baumannii
2005
Impact of Nosocomial Infections on Outcome: Myths and Evidence
1999
Origins and Evolution of Antibiotic Resistance
2010 Standout
Two Different Extended-Spectrum β-Lactamases (ESBLs) in One of the First ESBL-Producing Salmonella Isolates in Poland
2002
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Third-Generation Cephalosporin Resistance inShigella sonnei, Argentina
2001
IS CR Elements: Novel Gene-Capturing Systems of the 21st Century?
2006
Works of Beatriz Mirelis being referenced
2014
Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration
2010
Polymicrobial bacteremia in critically ill patients
1993
Evidence for convergent evolution of CTX-M-14 ESBL inEscherichia coliand its prevalence
2007
Comparison of macrorestriction analysis of genomic DNA by pulsed-field gel electrophoresis and ribotyping with conventional methods for differentiation of Escherichia coli 0124 isolates
1995
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
2008
Surveillance of extended-spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain
2005
Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis
2002
Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes
1994
Prulifloxacin: a new antibacterial fluoroquinolone
2006
Infections Caused By Escherichia Coli Resistant to Norfloxacin in Hospitalized Cirrhotic Patients
1999
Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction
1998
Characterization of the highly variable region surrounding the blaCTX-M-9 gene in non-related Escherichia coli from Barcelona
2005
In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria
1986
Lack of usefulness of blood cultures to diagnose ventilator-associated pneumonia
1991
Increase in Quinolone Resistance in a Haemophilus influenzae Strain Isolated from a Patient with Recurrent Respiratory Infections Treated with Ofloxacin
1999
Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain
2013
Molecular diagnosis of bloodstream infections with a new dual-priming oligonucleotide-based multiplex PCR assay
2013
Antibiotic Resistance Trends in Enteropathogenic Bacteria Isolated in 1985–1987 and 1995–1998 in Barcelona
2000
Bacteriophages and Diffusion of β-lactamase Genes
2004
Cephalosporin-resistantEscherichia coliamong Summer Camp Attendees with Salmonellosis
2003
Novel Complex sul1 -Type Integron in Escherichia coli Carrying bla CTX-M-9
2002
Escherichia coli Serotype O15:K52:H1 as a Uropathogenic Clone
2000
[Etiology of enteritis in a university general hospital in Barcelona (1992-1995)].
1997
Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period
2002
Salmonella enterica Serovar Virchow with CTX-M-Like β-Lactamase in Spain
2000
Increased Resistance to Quinolones in Campylobacter jejuni: A Genetic Analysis of gyrA Gene Mutations in Quinolone‐Resistant Clinical Isolates
1998
Clinical and microbiological features of nocardiosis 1997–2003
2007